Cetirizine Hydrochloride Tablet, Coated
Product Images NDC 62207-764

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cetirizine Hydrochloride (NDC 62207-764). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules India Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cet-label-30 (Cet Label 30)

Label for Cetirizine Hydrochloride Tablets USP 10 mg, film-coated tablets. The label states each tablet contains 10 mg of cetirizine hydrochloride and indicates a package size of 20,000 units. It shows batch number, manufacturing and expiration date placeholders, manufacturing license number, and NDC 62207-764-30. The label mentions storage conditions and cautions for repacking. It is manufactured by Granules India Limited, located in Telangana, India, with country of origin noted as India.*

FDA Label Image

Cet-label-88 (Cet Label 88)

Label for Cetirizine Hydrochloride Tablets USP, 10 mg, film-coated oral tablets. The label includes manufacturing details from Granules India Limited, batch number placeholder, manufacturing and expiry dates placeholders, net and gross weights, number of units as 100,000 tablets, and country of origin as India. The label features barcodes and storage instructions (store between 20° to 25°C).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.